Literature DB >> 3487652

Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole.

M H Thomas, L A Gutterman.   

Abstract

A 61-year-old patient with rheumatoid arthritis receiving treatment with methotrexate developed bone marrow hypoplasia after treatment with trimethoprim-sulfamethoxazole. The bone marrow recovered after stopping methotrexate.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3487652

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  8 in total

1.  Methotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprim.

Authors:  Navtej Sathi; Julie Dawson
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 2.980

2.  Methotrexate and trimethoprim-sulfamethoxazole: toxicity from this combination continues to occur.

Authors:  Jessica Cudmore; Matthew Seftel; Jeffrey Sisler; Ryan Zarychanski
Journal:  Can Fam Physician       Date:  2014-01       Impact factor: 3.275

3.  Use of methotrexate in older patients. A risk-benefit assessment.

Authors:  S E Tett; E J Triggs
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

Review 4.  Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis.

Authors:  Michael T Nurmohamed; Ben A C Dijkmans
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.

Authors:  Jirí Grim; Jaroslav Chládek; Jirina Martínková
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 6.  Methotrexate in rheumatoid arthritis. An update.

Authors:  B Bannwarth; L Labat; Y Moride; T Schaeverbeke
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

7.  A case of pancytopenia secondary to low-dose pulse methotrexate therapy in a patient with rheumatoid arthritis and renal insufficiency.

Authors:  G T Park; D W Jeon; K H Roh; H S Mun; C H Lee; C H Park; K W Kang; S M Kim; J M Kang; H C Park
Journal:  Korean J Intern Med       Date:  1999-01       Impact factor: 2.884

8.  A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole.

Authors:  Mohsin Hamid; Bilal Lashari; Irfan Ahsan; Ida Micaily; Usman Sarwar; Joseph Crocetti
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.